Abstract
hLDH-5 has emerged as a promising target for anti-glycolytic cancer chemotherapy. Here we report a first generation of bifunctional inhibitors, which show promising activity against hLDH-5.
Original language | English |
---|---|
Pages (from-to) | 230-2 |
Number of pages | 3 |
Journal | Chemical Communications |
Volume | 47 |
Issue number | 1 |
DOIs | |
Publication status | Published - 2011 |